---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-266154"
form_type: "8-K"
ticker: null
cik: "0001597553"
company_name: "Sage Therapeutics, Inc."
filed_at: "2024-11-26T23:59:59+00:00"
generated_at: "2026-05-29T17:52:04.574176+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Sage Therapeutics director Jeffrey M. Jonas to retire from Board effective Dec 1, 2024

## Summary
- Jeffrey M. Jonas notified the Board of his retirement effective December 1, 2024.
- Retirement not due to any disagreement with the Company on operations, policies, or practices.
- Jonas served as a member of the Board prior to retirement.

## SEC filing metadata
- accession: 0001193125-24-266154
- form_type: 8-K
- cik: 0001597553
- company_name: Sage Therapeutics, Inc.
- filed_at: 2024-11-26T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1597553/000119312524266154/0001193125-24-266154-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1597553/000119312524266154/d865403d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-266154
- JSON: https://secwatch.observer/filing/0001193125-24-266154.json
- Plain text: https://secwatch.observer/filing/0001193125-24-266154.txt

## Key facts
- Executive change
  Jeffrey M. Jonas retired as member of the Board of Directors at Sage Therapeutics, Inc..
  - Action: retired
  - Role: member of the Board of Directors
  source text: On November 22, 2024, Jeffrey M. Jonas, MD, a member of the Board of Directors (the “Board”) of Sage Therapeutics, Inc. (the “Company”), notified the Company of his retirement from the Board, effective as of December 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1597553/000119312524266154/0001193125-24-266154-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.